Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02445001

Erythrocyte Ghost Mediated Retinal Diagnosis

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

Instead of the usual procedure of injecting ICG dye directly into an arm vein, now the dye can be placed inside of RBCs. When a small volume of the RBC's with the dye is injected into a person's arm, the individual RBCs can be seen as they flow through the retinal blood vessels.

Detailed description

Capillary erythrocyte movement throughout the entire human macula can be observed routinely for periods up to 20 minutes by autologous re-injection of a small volume (about 1 mL) of indocyanine green (ICG)-loaded erythrocytes, making possible for the first time quantification of blood flow in individual capillaries, including abnormal structures like choroidal neovascularization (CNV), and it makes possible characterization of vasomotion in ocular vasculatures.

Conditions

Interventions

TypeNameDescription
PROCEDUREICG loaded erythrocytesFor each subject, on the morning of the day angiography was scheduled, or no longer than 4 days prior to angiography, 9 ml of blood will be withdrawn from an antecubital vein. Using sterile procedures, erythrocyte ghosts produced from the blood will be loaded with ICG dye (for the diagnostic part of the study) or with ICG and one of several drugs (for the therapeutic part of the study) by the following procedure, which requires about 2 hours and yields approximately 1 ml of packed cells (80% Ht) that, after microscopic examination, are ready for autologous re-injection

Timeline

Start date
2013-10-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2015-05-15
Last updated
2016-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02445001. Inclusion in this directory is not an endorsement.

Erythrocyte Ghost Mediated Retinal Diagnosis (NCT02445001) · Clinical Trials Directory